CLO-SCB-1019-003: Safety and Immunogenicity Study of SCB-1019T in Children (clinicaltrials.gov) - Jan 4, 2025 - P1 | N=0 | Withdrawn | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | N=112 ➔ 0 | Trial completion date: Jun 2026 ➔ Dec 2026 | Initiation date: Mar 2025 ➔ Oct 2025 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Jan 2026 ➔ Jun 2026
Enrollment change • Trial completion date • Trial initiation date • Trial primary completion date • Trial withdrawal • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections
|